Mutational analysis and molecular modeling of the binding pocket of the metabotropic glutamate 5 receptor negative modulator 2-methyl-6-(phenylethynyl)-pyridine

被引:125
|
作者
Malherbe, P
Kratochwil, N
Zenner, MT
Piussi, J
Diener, C
Kratzeisen, C
Fischer, C
Porter, RHP
机构
[1] F Hoffmann La Roche & Co Ltd, PRBN D, Pharma Div, Discovery Res CNS, CH-4070 Basel, Switzerland
[2] F Hoffmann La Roche & Co Ltd, Chem, CH-4070 Basel, Switzerland
关键词
D O I
10.1124/mol.64.4.823
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Metabotropic glutamate (mGlu) 5 is a G-protein-coupled metabotropic glutamate receptor that plays an important role as a modulator of synaptic plasticity, ion channel activity, and excitotoxicity. 2-Methyl-6-(phenylethynyl)-pyridine ( MPEP) is a highly potent, noncompetitive, selective, and systemically active antagonist of mGlu5 receptors. It binds to a novel allosteric site that resides within the seven-transmembrane domain of mGlu5 receptors. Using site-directed mutagenesis, [H-3]MPEP binding, a functional Ca2+ mobilization assay, and rhodopsin-based homology modeling, we identified eight residues (Pro-654(3.36), Tyr-658(3.40), Leu-743(5.47), Thr-780(6.44), Trp-784(6.48), Phe-787(6.51), Tyr-791(6.55), and Ala-809(7.47)) that are crucial for MPEP-binding to rat mGlu5 receptors. Four mutations, Y658(3.40)V, W784(6.48)A, F787(6.51)A, and A809(7.47)V, caused complete loss of [ 3H] MPEP binding and also blocked the MPEP-mediated inhibition of quisqualate-induced intracellular Ca2+ mobilization. To visualize these experimental findings, we have constructed a homology model based on the X-ray crystal of bovine rhodopsin and have suggested a possible binding mode of MPEP. We propose that MPEP via its interactions with a network of the aromatic residues including Phe-658(3.40) in transmembrane (TM) 3 helix and Trp-798(6.48), Phe-787(6.51), and Tyr-791(6.55) in TM6 helix prevents the movement of TM6 helix relative to TM3 helix, a step that is required for receptor activation, and consequently stabilizes the inactive conformation of mGlu5 receptor. In the TM6 region, we observed a striking similarity between the critical residues involved in MPEP-binding site with those of previously identified as 1-ethyl-2-methyl-6-oxo-4-(1,2,4,5-tetrahydro-benzo[d]azepin-3-yl)-1,6-dihydropyrimidine-5-carbonitrile-binding pocket of mGlu1, pointing to a common mechanism of inhibition shared by both antagonists.
引用
收藏
页码:823 / 832
页数:10
相关论文
共 50 条
  • [1] Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodents
    Spooren, WPJM
    Vassout, A
    Neijt, HC
    Kuhn, R
    Gasparini, F
    Roux, S
    Porsolt, RD
    Gentsch, C
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2000, 295 (03): : 1267 - 1275
  • [2] The metabotropic glutamate receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) blocks fear conditioning in rats
    Schulz, B
    Fendt, M
    Gasparini, F
    Lingenhöhl, K
    Kuhn, R
    Koch, M
    [J]. NEUROPHARMACOLOGY, 2001, 41 (01) : 1 - 7
  • [3] Identification of Novel Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Acting at Site Distinct from 2-Methyl-6-(phenylethynyl)-pyridine Binding
    Butkiewicz, Mariusz
    Rodriguez, Alice L.
    Rainey, Shane E.
    Wieling, Joshua
    Luscombe, Vincent B.
    Stauffer, Shaun R.
    Lindsley, Craig W.
    Conn, P. Jeffrey
    Meiler, Jens
    [J]. ACS CHEMICAL NEUROSCIENCE, 2019, 10 (08): : 3427 - 3436
  • [4] 2-Methyl-6-(phenylethynyl)pyridine Hydrochloride Modulates Metabotropic Glutamate 5 Receptors Endogenously Expressed in Zebrafish Brain
    Luis Albasanz, Jose
    Santana, Soraya
    Guzman-Sanchez, Fernando
    Leon, David
    Burgos, Javier S.
    Martin, Mairena
    [J]. ACS CHEMICAL NEUROSCIENCE, 2016, 7 (12): : 1690 - 1697
  • [5] Attenuation of behavioral effects of cocaine by the metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)-pyridine in squirrel monkeys: Comparison with dizocilpine
    Lee, B
    Platt, DM
    Rowlett, JK
    Adewale, AS
    Spealman, RD
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 312 (03): : 1232 - 1240
  • [6] In vivo evidence that the metabotropic glutamate receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) acts as an inhibitor of the norepinephrine transporter
    Heidbreder, C
    Bianchi, M
    Lacroix, L
    Crespi, F
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2003, 138 : U104 - U104
  • [7] Anti-hyperalgesic effects of the novel metabotropic glutamate receptor 5 antagonist, 2-methyl-6-(phenylethynyl)-pyridine, in rat models of inflammatory pain
    Bowes, M
    Panesar, M
    Gentry, C
    Urban, L
    Gasparini, F
    Kuhn, R
    Walker, K
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 : U130 - U130
  • [8] Effect of metabotropic glutamate receptor subtype 5 antagonist, 2-methyl-6-(phenylethynyl)-pyridine on mechanosensory afferents innervating rat hind paw following inflammation
    Su, X
    Urban, MO
    [J]. NEUROSCIENCE LETTERS, 2005, 390 (03) : 123 - 128
  • [9] The Metabotropic Glutamate Receptor Subtype 5 Antagonist Fenobam Is Analgesic and Has Improved in Vivo Selectivity Compared with the Prototypical Antagonist 2-Methyl-6-(phenylethynyl)-pyridine
    Montana, Michael C.
    Cavallone, Laura F.
    Stubbert, Kristi K.
    Stefanescu, Andrei D.
    Kharasch, Evan D.
    Gereau, Robert W.
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 330 (03): : 834 - 843
  • [10] METABOTROPIC GLUTAMATE RECEPTOR 5 ANTAGONIST 2-METHYL-6-(PHENYLETHYNYL)PYRIDINE PRODUCES ANTIDEPRESSANT EFFECTS IN RATS: ROLE OF BRAIN-DERIVED NEUROTROPHIC FACTOR
    Liu, C. Y.
    Jiang, X. X.
    Zhu, Y. H.
    Wei, D. N.
    [J]. NEUROSCIENCE, 2012, 223 : 219 - 224